Hybrid positron emission tomography-magnetic resonance imaging with gallium 68 prostate-specific membrane antigen tracer: a next step for imaging of recurrent prostate cancer-preliminary results

Eur Urol. 2013 Nov;64(5):862-4. doi: 10.1016/j.eururo.2013.08.003. Epub 2013 Aug 9.

Authors

Matthias C Roethke¹, Timur H Kuru, Ali Afshar-Oromieh, Heinz-Peter Schlemmer, Boris A Hadaschik, Michael Fenchel

Affiliation

¹ Department of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: m.roethke@dkfz-heidelberg.de.

PMID: 23954084
DOI: 10.1016/j.eururo.2013.08.003

No abstract available

Publication types

Letter

MeSH terms

Aged
Antigens, Surface / analysis*
Biomarkers, Tumor / analysis*
Edetic Acid / analogs & derivatives*
Gallium Isotopes
Gallium Radioisotopes
Glutamate Carboxypeptidase II / analysis*
Humans
Magnetic Resonance Imaging*
Male
Middle Aged
Multimodal Imaging / methods*
Neoplasm Recurrence, Local / diagnosis*
Neoplasm Recurrence, Local / diagnostic imaging
Neoplasm Recurrence, Local / enzymology
Neoplasm Recurrence, Local / pathology
Oligopeptides*
Positron-Emission Tomography*
Predictive Value of Tests
Prognosis
Prostatic Neoplasms / diagnosis*
Prostatic Neoplasms / diagnostic imaging
Prostatic Neoplasms / enzymology
Prostatic Neoplasms / pathology
Radiopharmaceuticals*
Whole Body Imaging

Substances

Antigens, Surface
Biomarkers, Tumor
Gallium Isotopes
Gallium Radioisotopes
Oligopeptides
Radiopharmaceuticals
gallium 68 PSMA-11
Edetic Acid
FOLH1 protein, human
Glutamate Carboxypeptidase II